Gene Therapy and Hemophilia: Where Do We Go from Here?
Nancy S Bolous,1 Nidhi Bhatt,2 Nickhill Bhakta,1 Ellis J Neufeld,2 Andrew M Davidoff,3 Ulrike M Reiss2 1Department of Global Pediatric Medicine – St. Jude Children’s Research Hospital, Memphis, TN, USA; 2Department of Hematology – St. Jude Children’s Research...
Main Authors: | Bolous NS, Bhatt N, Bhakta N, Neufeld EJ, Davidoff AM, Reiss UM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/gene-therapy-and-hemophilia-where-do-we-go-from-here-peer-reviewed-fulltext-article-JBM |
Similar Items
-
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus
by: John Puetz
Published: (2023-11-01) -
“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India
by: Sangita Darshan Shah, et al.
Published: (2019-01-01) -
Hemofilia II. Aspectos moleculares y de genética poblacional Hemophilia II. Molecular and population genetics
by: Dunia Castillo-González
Published: (2012-06-01) -
Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh
by: Mohammed Nadimul Islam, et al.
Published: (2022-07-01) -
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
by: Tine M.H.J. Goedhart, et al.
Published: (2022-01-01)